318 related articles for article (PubMed ID: 15540922)
41. Local delivery of minocycline and systemic BCNU have synergistic activity in the treatment of intracranial glioma.
Frazier JL; Wang PP; Case D; Tyler BM; Pradilla G; Weingart JD; Brem H
J Neurooncol; 2003 Sep; 64(3):203-9. PubMed ID: 14558595
[TBL] [Abstract][Full Text] [Related]
42. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
[TBL] [Abstract][Full Text] [Related]
43. MiR-21 enhanced glioma cells resistance to carmustine via decreasing Spry2 expression.
Wang GB; Liu JH; Hu J; Xue K
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5065-5071. PubMed ID: 29228450
[TBL] [Abstract][Full Text] [Related]
44. Differential response to 1,3-bis (2-chloroethyl)-1-nitrosourea in drug-resistant and -sensitive 9L rat brain tumor cells pretreated with alpha-difluoromethylornithine and 6-thioguanine.
Hunter KJ; Deen DF; Marton LJ
Int J Cancer; 1989 Oct; 44(4):658-60. PubMed ID: 2507451
[TBL] [Abstract][Full Text] [Related]
45. Comparison of intravenous versus intracarotid therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea in a rat brain tumor model.
Bullard DE; Bigner SH; Bigner DD
Cancer Res; 1985 Nov; 45(11 Pt 1):5240-5. PubMed ID: 4053004
[TBL] [Abstract][Full Text] [Related]
46. In vivo 31P nuclear magnetic resonance spectroscopy of rat 9L gliosarcoma treated with BCNU: dose response of spectral changes.
Steen RG; Tamargo RJ; Brem H; Glickson JD; Wehrle JP
Magn Reson Med; 1989 Aug; 11(2):258-66. PubMed ID: 2779416
[TBL] [Abstract][Full Text] [Related]
47. In vivo 31P nuclear magnetic resonance spectroscopy of subcutaneous 9L gliosarcoma: effects of tumor growth and treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea on tumor bioenergetics and histology.
Sijens PE; Bovee WM
Cancer Res; 1988 Oct; 48(19):5610-1. PubMed ID: 3416313
[No Abstract] [Full Text] [Related]
48. Development of resistance to antiglioma agents in rat C6 cells caused collateral sensitivity to doxorubicin.
Stojković S; Podolski-Renić A; Dinić J; Stanković T; Banković J; Hadžić S; Paunović V; Isaković A; Tanić N; Pešić M
Exp Cell Res; 2015 Jul; 335(2):248-57. PubMed ID: 26026740
[TBL] [Abstract][Full Text] [Related]
49. Response of 9L rat brain tumor multicellular spheroids to single and fractionated doses of 1,3-bis(2-chloroethyl)-1-nitrosourea.
Sano Y; Hoshino T; Barker M; Deen DF
Cancer Res; 1984 Feb; 44(2):571-6. PubMed ID: 6692362
[TBL] [Abstract][Full Text] [Related]
50. Cytotoxicity and induction of sister chromatid exchanges in human and rodent brain tumor cells treated with alkylating chemotherapeutic agents.
Tokuda K; Bodell WJ
Cancer Res; 1988 Jun; 48(11):3100-5. PubMed ID: 2835151
[TBL] [Abstract][Full Text] [Related]
51. [Possibility of overcoming ACNU resistance in ACNU-resistant sublines of rat brain tumors in vitro by a calmodulin inhibitor].
Yoshida T; Shimizu K; Mogami H; Sakamoto Y; Egawa T
No Shinkei Geka; 1987 Feb; 15(2):143-9. PubMed ID: 3470626
[TBL] [Abstract][Full Text] [Related]
52. Honokiol crosses BBB and BCSFB, and inhibits brain tumor growth in rat 9L intracerebral gliosarcoma model and human U251 xenograft glioma model.
Wang X; Duan X; Yang G; Zhang X; Deng L; Zheng H; Deng C; Wen J; Wang N; Peng C; Zhao X; Wei Y; Chen L
PLoS One; 2011 Apr; 6(4):e18490. PubMed ID: 21559510
[TBL] [Abstract][Full Text] [Related]
53. Resistance to DNA Damaging Agents Produced Invasive Phenotype of Rat Glioma Cells-Characterization of a New in Vivo Model.
Stojković S; Podolski-Renić A; Dinić J; Pavković Ž; Ayuso JM; Fernández LJ; Ochoa I; Pérez-García VM; Pešić V; Pešić M
Molecules; 2016 Jun; 21(7):. PubMed ID: 27355941
[TBL] [Abstract][Full Text] [Related]
54. [Meningeal gliomatosis models as a chemosensitivity assay system].
Yoshida T; Shimizu K; Ushio Y; Hayakawa T; Mogami H; Nakata Y; Sakamoto Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3):458-63. PubMed ID: 6584085
[TBL] [Abstract][Full Text] [Related]
55. Carbamoylating chemoresistance induced by cobalt pretreatment in C6 glioma cells: putative roles of hypoxia-inducible factor-1.
Yang DI; Chen SD; Yang YT; Ju TC; Xu JM; Hsu CY
Br J Pharmacol; 2004 Mar; 141(6):988-96. PubMed ID: 14980978
[TBL] [Abstract][Full Text] [Related]
56. Response to BCNU of spheroids grown from mixtures of drug-sensitive and drug-resistant cells.
Tofilon PJ; Arundel CM; Deen DF
Cancer Chemother Pharmacol; 1987; 20(2):89-95. PubMed ID: 3664937
[TBL] [Abstract][Full Text] [Related]
57. [Development of ACNU-resistant meningeal gliomatosis models: establishment of resistant rat glioma subline against ACNU].
Yoshida T; Ushio Y; Hayakawa T; Yamada K; Kato A; Mogami H; Nakata Y
No Shinkei Geka; 1984 Aug; 12(9):1029-36. PubMed ID: 6594599
[TBL] [Abstract][Full Text] [Related]
58. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
Zhao JX; Yang LP; Wang YF; Qin LP; Liu DQ; Bai CX; Nan X; Shi SS; Pei XJ
Eur J Neurol; 2007 May; 14(5):510-6. PubMed ID: 17437609
[TBL] [Abstract][Full Text] [Related]
59. Differential potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea by alpha-difluoromethylornithine in chloroethylnitrosourea-sensitive and -resistant 9L rat brain tumor cells in vitro.
Oredsson SM; Tofilon PJ; Feuerstein BG; Deen DF; Rosenblum ML; Marton LJ
Cancer Res; 1983 Aug; 43(8):3576-8. PubMed ID: 6407751
[TBL] [Abstract][Full Text] [Related]
60. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors.
Levin VA; Kabra PA; Freeman-Dove MA
Cancer Chemother Pharmacol; 1978; 1(4):233-42. PubMed ID: 750110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
